X
  • Lawrence Livermore National Laboratory has joined with partners at other national labs, industry, and academia in the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, aimed at creating a new paradigm of cancer drug discovery that would reduce the time from an identified drug target to clinical candidate from six years to just 12 months.
    Lawrence Livermore National Laboratory has joined with partners at other national labs, industry, and academia in the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, aimed at creating a new paradigm of cancer drug discovery that would reduce the time from an identified drug target to clinical candidate from six years to just 12 months.
Chat now!
1.78713